Gitman Paul
Director at BIOSPECIFICS TECHNOLOGIES CORP
- Sold, on record
- $9M
- Dollars the filings state
- Form 4 sales
- 18
- Latest May 15, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOSPECIFICS TECHNOLOGIES CORPDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualMay 27, 2015 2015
Sold 24,000 shares at $42.00 ($1M)
Gitman Paul, Director
Sold 26.4% of holdings ($3.8M position)66,825 shares left3.3x usual sizeFiling
- 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedMay 29, 2015 +2 days
Sold 15,000 shares at $46.76 ($701k)
Gitman Paul, Director
Sold 22.4% of holdings ($3.1M position)51,825 shares left2x usual sizeFiling
- 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualJun 23, 2015 +25 days
Sold 36,308 shares at $51.78 ($1.9M)
Gitman Paul, Director
Sold 41.2% of holdings ($4.6M position)51,825 shares left4.1x usual sizeFiling
- 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedJul 20, 2015 +27 days
Sold 8,692 shares at $53.00 ($461k)
Gitman Paul, Director
Sold 14.4% of holdings ($3.2M position)51,825 shares left0.9x usual sizeFiling
- 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedAug 24, 2018 +1131 days
Sold 11,825 shares at $51.17 ($605k)
Gitman Paul, Director
Sold 22.8% of holdings ($2.7M position)40,000 shares leftFirst sale on recordFiling
- 6 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualAug 29, 2018 +5 days
Sold 20,000 shares at $49.72 ($994k)
Gitman Paul, Director
Sold 50% of holdings ($2M position)20,000 shares leftFiling
- 7 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 7, 2018 +9 days
Sold 1,000 shares at $57.64 ($58k)
Gitman Paul, Director
Sold 4.8% of holdings ($1.2M position)20,000 shares leftFiling
- 8 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualMay 15, 2019 +250 days
Sold 5,000 shares at $65.83 ($329k)
Gitman Paul, Director
Sold 25% of holdings ($1.3M position)15,000 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2019 | May 17, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 5,000 | $329k | 25.0% | Unusual | SEC |
| Sep 7, 2018 | Sep 7, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 1,000 | $58k | 4.8% | Plan not stated | SEC |
| Aug 29, 2018 | Aug 29, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 20,000 | $994k | 50.0% | Unusual | SEC |
| Aug 24, 2018 | Aug 27, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 11,825 | $605k | 22.8% | Plan not stated | SEC |
| Jul 20, 2015 | Jul 21, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 8,692 | $461k | 14.4% | Plan not stated | SEC |
| Jun 23, 2015 | Jun 25, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 36,308 | $1.9M | 41.2% | Unusual | SEC |
| May 29, 2015 | Jun 1, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 15,000 | $701k | 22.4% | Plan not stated | SEC |
| May 27, 2015 | May 28, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 24,000 | $1M | 26.4% | Unusual | SEC |
| Jan 23, 2015 | Jan 26, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 5,887 | $241k | 8.8% | Plan not stated | SEC |
| Jan 16, 2015 | Jan 20, 2015 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 4,113 | $169k | 6.2% | Plan not stated | SEC |
| Nov 24, 2014 | Nov 26, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 7,600 | $300k | 10.2% | Plan not stated | SEC |
| Jun 12, 2014 | Jun 16, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 10,000 | $280k | 14.4% | Plan not stated | SEC |
| Jan 23, 2014 | Jan 23, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 10,000 | $250k | 14.4% | Plan not stated | SEC |
| Dec 9, 2013 | Dec 11, 2013 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 15,000 | $345k | 20.2% | Plan not stated | SEC |
| Nov 18, 2013 | Nov 20, 2013 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 7,000 | $154k | 10.5% | Plan not stated | SEC |
| Nov 11, 2013 | Nov 12, 2013 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 5,000 | $100k | 7.0% | Plan not stated | SEC |
| Sep 15, 2009 | Sep 17, 2009 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 12,500 | $343k | 25.8% | Unusual | SEC |
| Sep 15, 2009 | Sep 15, 2009 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 27,500 | $741k | 36.2% | Unusual | SEC |